APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nuclear Medicine Imaging Agents

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nuclear Medicine Imaging Agents Market Analysis and Forecast 2026-2032

26 December 2025196 pages

Choose your research edition.

Industry ResearchNuclear Medicine Imaging Agents Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclear Medicine Imaging Agents Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Nuclear Medicine Imaging Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclear Medicine Imaging Agents Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclear Medicine Imaging Agents Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Nuclear Medicine Imaging Agents market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nuclear Medicine Imaging Agents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nuclear Medicine Imaging Agents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nuclear Medicine Imaging Agents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nuclear Medicine Imaging Agents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Nuclear Medicine Imaging Agents include Jubilant Pharma Limited, Foshan Rui Diao Pharmaceutical, Yantai Dongcheng, Navidea, Mallinckrodt, Lantheus, Guerbet, GE HealthCare and Eli Lilly and Company, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nuclear Medicine Imaging Agents, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nuclear Medicine Imaging Agents, also provides the sales of main regions and countries. Of the upcoming market potential for Nuclear Medicine Imaging Agents, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nuclear Medicine Imaging Agents sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nuclear Medicine Imaging Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nuclear Medicine Imaging Agents sales, projected growth trends, production technology, application and end-user industry.

Nuclear Medicine Imaging Agents Segment by Company

Jubilant Pharma Limited

Foshan Rui Diao Pharmaceutical

Yantai Dongcheng

Navidea

Mallinckrodt

Lantheus

Guerbet

GE HealthCare

Eli Lilly and Company

Cardinal Health

Bracco Diagnostic

Blue Earth Diagnostics

Bayer AG

Abx Advanced Biochemical

Nuclear Medicine Imaging Agents Segment by Type

Nitrogen 13 Labeling

Technetium 99 Labeling

Fluorine 18 Labeling

Carbon 11 Labeling

Oxygen 15 Labeling

Others

Nuclear Medicine Imaging Agents Segment by Application

Clinical Stage

Early Diagnosis

Treatment Evaluation

Nuclear Medicine Imaging Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine Imaging Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine Imaging Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine Imaging Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Nuclear Medicine Imaging Agents in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Nuclear Medicine Imaging Agents manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nuclear Medicine Imaging Agents sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nuclear Medicine Imaging Agents Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Nitrogen 13 Labeling Major Manufacturers Table 3. Technetium 99 Labeling Major Manufacturers Table 4. Fluorine 18 Labeling Major Manufacturers Table 5. Carbon 11 Labeling Major Manufacturers Table 6. Oxygen 15 Labeling Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Nuclear Medicine Imaging Agents Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Clinical Stage Major Manufacturers Table 10. Early Diagnosis Major Manufacturers Table 11. Treatment Evaluation Major Manufacturers Table 12. Nuclear Medicine Imaging Agents Industry Trends Table 13. Nuclear Medicine Imaging Agents Industry Drivers Table 14. Nuclear Medicine Imaging Agents Industry Opportunities and Challenges Table 15. Nuclear Medicine Imaging Agents Industry Restraints Table 16. Global Nuclear Medicine Imaging Agents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Nuclear Medicine Imaging Agents Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Nuclear Medicine Imaging Agents Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Nuclear Medicine Imaging Agents Revenue Market Share by Region (2021-2026) Table 20. Global Nuclear Medicine Imaging Agents Revenue Market Share by Region (2027-2032) Table 21. Global Nuclear Medicine Imaging Agents Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 22. Global Nuclear Medicine Imaging Agents Sales by Region (2021-2026) & (K Units) Table 23. Global Nuclear Medicine Imaging Agents Sales by Region (2027-2032) & (K Units) Table 24. Global Nuclear Medicine Imaging Agents Sales Market Share by Region (2021-2026) Table 25. Global Nuclear Medicine Imaging Agents Sales Market Share by Region (2027-2032) Table 26. Global Nuclear Medicine Imaging Agents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Nuclear Medicine Imaging Agents Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Nuclear Medicine Imaging Agents Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Nuclear Medicine Imaging Agents Sales Market Share by Manufacturers (2021-2026) Table 30. Global Nuclear Medicine Imaging Agents Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 31. Global Nuclear Medicine Imaging Agents Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Nuclear Medicine Imaging Agents Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Nuclear Medicine Imaging Agents Manufacturers, Product Type & Application Table 34. Global Nuclear Medicine Imaging Agents Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Nuclear Medicine Imaging Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Nuclear Medicine Imaging Agents Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Nuclear Medicine Imaging Agents Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Nuclear Medicine Imaging Agents Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Nuclear Medicine Imaging Agents Revenue Market Share by Type (2021-2026) Table 41. Global Nuclear Medicine Imaging Agents Revenue Market Share by Type (2027-2032) Table 42. Global Nuclear Medicine Imaging Agents Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 43. Global Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units) Table 44. Global Nuclear Medicine Imaging Agents Sales by Type (2027-2032) & (K Units) Table 45. Global Nuclear Medicine Imaging Agents Sales Market Share by Type (2021-2026) Table 46. Global Nuclear Medicine Imaging Agents Sales Market Share by Type (2027-2032) Table 47. Global Nuclear Medicine Imaging Agents Price by Type (2021-2026) & (US$/Unit) Table 48. Global Nuclear Medicine Imaging Agents Price by Type (2027-2032) & (US$/Unit) Table 49. Global Nuclear Medicine Imaging Agents Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Nuclear Medicine Imaging Agents Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Nuclear Medicine Imaging Agents Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Nuclear Medicine Imaging Agents Revenue Market Share by Application (2021-2026) Table 53. Global Nuclear Medicine Imaging Agents Revenue Market Share by Application (2027-2032) Table 54. Global Nuclear Medicine Imaging Agents Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 55. Global Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units) Table 56. Global Nuclear Medicine Imaging Agents Sales by Application (2027-2032) & (K Units) Table 57. Global Nuclear Medicine Imaging Agents Sales Market Share by Application (2021-2026) Table 58. Global Nuclear Medicine Imaging Agents Sales Market Share by Application (2027-2032) Table 59. Global Nuclear Medicine Imaging Agents Price by Application (2021-2026) & (US$/Unit) Table 60. Global Nuclear Medicine Imaging Agents Price by Application (2027-2032) & (US$/Unit) Table 61. Jubilant Pharma Limited Company Information Table 62. Jubilant Pharma Limited Business Overview Table 63. Jubilant Pharma Limited Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product Portfolio Table 65. Jubilant Pharma Limited Recent Development Table 66. Foshan Rui Diao Pharmaceutical Company Information Table 67. Foshan Rui Diao Pharmaceutical Business Overview Table 68. Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product Portfolio Table 70. Foshan Rui Diao Pharmaceutical Recent Development Table 71. Yantai Dongcheng Company Information Table 72. Yantai Dongcheng Business Overview Table 73. Yantai Dongcheng Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Yantai Dongcheng Nuclear Medicine Imaging Agents Product Portfolio Table 75. Yantai Dongcheng Recent Development Table 76. Navidea Company Information Table 77. Navidea Business Overview Table 78. Navidea Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Navidea Nuclear Medicine Imaging Agents Product Portfolio Table 80. Navidea Recent Development Table 81. Mallinckrodt Company Information Table 82. Mallinckrodt Business Overview Table 83. Mallinckrodt Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Mallinckrodt Nuclear Medicine Imaging Agents Product Portfolio Table 85. Mallinckrodt Recent Development Table 86. Lantheus Company Information Table 87. Lantheus Business Overview Table 88. Lantheus Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Lantheus Nuclear Medicine Imaging Agents Product Portfolio Table 90. Lantheus Recent Development Table 91. Guerbet Company Information Table 92. Guerbet Business Overview Table 93. Guerbet Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Guerbet Nuclear Medicine Imaging Agents Product Portfolio Table 95. Guerbet Recent Development Table 96. GE HealthCare Company Information Table 97. GE HealthCare Business Overview Table 98. GE HealthCare Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. GE HealthCare Nuclear Medicine Imaging Agents Product Portfolio Table 100. GE HealthCare Recent Development Table 101. Eli Lilly and Company Company Information Table 102. Eli Lilly and Company Business Overview Table 103. Eli Lilly and Company Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Eli Lilly and Company Nuclear Medicine Imaging Agents Product Portfolio Table 105. Eli Lilly and Company Recent Development Table 106. Cardinal Health Company Information Table 107. Cardinal Health Business Overview Table 108. Cardinal Health Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Cardinal Health Nuclear Medicine Imaging Agents Product Portfolio Table 110. Cardinal Health Recent Development Table 111. Bracco Diagnostic Company Information Table 112. Bracco Diagnostic Business Overview Table 113. Bracco Diagnostic Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Bracco Diagnostic Nuclear Medicine Imaging Agents Product Portfolio Table 115. Bracco Diagnostic Recent Development Table 116. Blue Earth Diagnostics Company Information Table 117. Blue Earth Diagnostics Business Overview Table 118. Blue Earth Diagnostics Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product Portfolio Table 120. Blue Earth Diagnostics Recent Development Table 121. Bayer AG Company Information Table 122. Bayer AG Business Overview Table 123. Bayer AG Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Bayer AG Nuclear Medicine Imaging Agents Product Portfolio Table 125. Bayer AG Recent Development Table 126. Abx Advanced Biochemical Company Information Table 127. Abx Advanced Biochemical Business Overview Table 128. Abx Advanced Biochemical Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product Portfolio Table 130. Abx Advanced Biochemical Recent Development Table 131. North America Nuclear Medicine Imaging Agents Revenue by Type (2021-2026) & (US$ Million) Table 132. North America Nuclear Medicine Imaging Agents Revenue by Type (2027-2032) & (US$ Million) Table 133. North America Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units) Table 134. North America Nuclear Medicine Imaging Agents Sales by Type (2027-2032) & (K Units) Table 135. North America Nuclear Medicine Imaging Agents Sales Price by Type (2021-2026) & (US$/Unit) Table 136. North America Nuclear Medicine Imaging Agents Sales Price by Type (2027-2032) & (US$/Unit) Table 137. North America Nuclear Medicine Imaging Agents Revenue by Application (2021-2026) & (US$ Million) Table 138. North America Nuclear Medicine Imaging Agents Revenue by Application (2027-2032) & (US$ Million) Table 139. North America Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units) Table 140. North America Nuclear Medicine Imaging Agents Sales by Application (2027-2032) & (K Units) Table 141. North America Nuclear Medicine Imaging Agents Sales Price by Application (2021-2026) & (US$/Unit) Table 142. North America Nuclear Medicine Imaging Agents Sales Price by Application (2027-2032) & (US$/Unit) Table 143. North America Nuclear Medicine Imaging Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. North America Nuclear Medicine Imaging Agents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. North America Nuclear Medicine Imaging Agents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. North America Nuclear Medicine Imaging Agents Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 147. North America Nuclear Medicine Imaging Agents Sales by Country (2021-2026) & (K Units) Table 148. North America Nuclear Medicine Imaging Agents Sales by Country (2027-2032) & (K Units) Table 149. North America Nuclear Medicine Imaging Agents Sales Price by Country (2021-2026) & (US$/Unit) Table 150. North America Nuclear Medicine Imaging Agents Sales Price by Country (2027-2032) & (US$/Unit) Table 151. United States Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 152. Canada Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 153. Mexico Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 154. Europe Nuclear Medicine Imaging Agents Revenue by Type (2021-2026) & (US$ Million) Table 155. Europe Nuclear Medicine Imaging Agents Revenue by Type (2027-2032) & (US$ Million) Table 156. Europe Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units) Table 157. Europe Nuclear Medicine Imaging Agents Sales by Type (2027-2032) & (K Units) Table 158. Europe Nuclear Medicine Imaging Agents Sales Price by Type (2021-2026) & (US$/Unit) Table 159. Europe Nuclear Medicine Imaging Agents Sales Price by Type (2027-2032) & (US$/Unit) Table 160. Europe Nuclear Medicine Imaging Agents Revenue by Application (2021-2026) & (US$ Million) Table 161. Europe Nuclear Medicine Imaging Agents Revenue by Application (2027-2032) & (US$ Million) Table 162. Europe Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units) Table 163. Europe Nuclear Medicine Imaging Agents Sales by Application (2027-2032) & (K Units) Table 164. Europe Nuclear Medicine Imaging Agents Sales Price by Application (2021-2026) & (US$/Unit) Table 165. Europe Nuclear Medicine Imaging Agents Sales Price by Application (2027-2032) & (US$/Unit) Table 166. Europe Nuclear Medicine Imaging Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. Europe Nuclear Medicine Imaging Agents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 168. Europe Nuclear Medicine Imaging Agents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 169. Europe Nuclear Medicine Imaging Agents Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 170. Europe Nuclear Medicine Imaging Agents Sales by Country (2021-2026) & (K Units) Table 171. Europe Nuclear Medicine Imaging Agents Sales by Country (2027-2032) & (K Units) Table 172. Europe Nuclear Medicine Imaging Agents Sales Price by Country (2021-2026) & (US$/Unit) Table 173. Europe Nuclear Medicine Imaging Agents Sales Price by Country (2027-2032) & (US$/Unit) Table 174. Germany Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 175. France Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 176. U.K. Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 177. Italy Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 178. Russia Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 179. Spain Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 180. Netherlands Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 181. Switzerland Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 182. Sweden Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 183. Poland Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 184. China Nuclear Medicine Imaging Agents Revenue by Type (2021-2026) & (US$ Million) Table 185. China Nuclear Medicine Imaging Agents Revenue by Type (2027-2032) & (US$ Million) Table 186. China Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units) Table 187. China Nuclear Medicine Imaging Agents Sales by Type (2027-2032) & (K Units) Table 188. China Nuclear Medicine Imaging Agents Sales Price by Type (2021-2026) & (US$/Unit) Table 189. China Nuclear Medicine Imaging Agents Sales Price by Type (2027-2032) & (US$/Unit) Table 190. China Nuclear Medicine Imaging Agents Revenue by Application (2021-2026) & (US$ Million) Table 191. China Nuclear Medicine Imaging Agents Revenue by Application (2027-2032) & (US$ Million) Table 192. China Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units) Table 193. China Nuclear Medicine Imaging Agents Sales by Application (2027-2032) & (K Units) Table 194. China Nuclear Medicine Imaging Agents Sales Price by Application (2021-2026) & (US$/Unit) Table 195. China Nuclear Medicine Imaging Agents Sales Price by Application (2027-2032) & (US$/Unit) Table 196. Asia Nuclear Medicine Imaging Agents Revenue by Type (2021-2026) & (US$ Million) Table 197. Asia Nuclear Medicine Imaging Agents Revenue by Type (2027-2032) & (US$ Million) Table 198. Asia Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units) Table 199. Asia Nuclear Medicine Imaging Agents Sales by Type (2027-2032) & (K Units) Table 200. Asia Nuclear Medicine Imaging Agents Sales Price by Type (2021-2026) & (US$/Unit) Table 201. Asia Nuclear Medicine Imaging Agents Sales Price by Type (2027-2032) & (US$/Unit) Table 202. Asia Nuclear Medicine Imaging Agents Revenue by Application (2021-2026) & (US$ Million) Table 203. Asia Nuclear Medicine Imaging Agents Revenue by Application (2027-2032) & (US$ Million) Table 204. Asia Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units) Table 205. Asia Nuclear Medicine Imaging Agents Sales by Application (2027-2032) & (K Units) Table 206. Asia Nuclear Medicine Imaging Agents Sales Price by Application (2021-2026) & (US$/Unit) Table 207. Asia Nuclear Medicine Imaging Agents Sales Price by Application (2027-2032) & (US$/Unit) Table 208. Asia Nuclear Medicine Imaging Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 209. Asia Nuclear Medicine Imaging Agents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 210. Asia Nuclear Medicine Imaging Agents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 211. Asia Nuclear Medicine Imaging Agents Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 212. Asia Nuclear Medicine Imaging Agents Sales by Country (2021-2026) & (K Units) Table 213. Asia Nuclear Medicine Imaging Agents Sales by Country (2027-2032) & (K Units) Table 214. Asia Nuclear Medicine Imaging Agents Sales Price by Country (2021-2026) & (US$/Unit) Table 215. Asia Nuclear Medicine Imaging Agents Sales Price by Country (2027-2032) & (US$/Unit) Table 216. Japan Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 217. South Korea Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 218. India Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 219. Australia Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 220. Taiwan Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 221. Southeast Asia Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 222. SAMEA Nuclear Medicine Imaging Agents Revenue by Type (2021-2026) & (US$ Million) Table 223. SAMEA Nuclear Medicine Imaging Agents Revenue by Type (2027-2032) & (US$ Million) Table 224. SAMEA Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units) Table 225. SAMEA Nuclear Medicine Imaging Agents Sales by Type (2027-2032) & (K Units) Table 226. SAMEA Nuclear Medicine Imaging Agents Sales Price by Type (2021-2026) & (US$/Unit) Table 227. SAMEA Nuclear Medicine Imaging Agents Sales Price by Type (2027-2032) & (US$/Unit) Table 228. SAMEA Nuclear Medicine Imaging Agents Revenue by Application (2021-2026) & (US$ Million) Table 229. SAMEA Nuclear Medicine Imaging Agents Revenue by Application (2027-2032) & (US$ Million) Table 230. SAMEA Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units) Table 231. SAMEA Nuclear Medicine Imaging Agents Sales by Application (2027-2032) & (K Units) Table 232. SAMEA Nuclear Medicine Imaging Agents Sales Price by Application (2021-2026) & (US$/Unit) Table 233. SAMEA Nuclear Medicine Imaging Agents Sales Price by Application (2027-2032) & (US$/Unit) Table 234. SAMEA Nuclear Medicine Imaging Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 235. SAMEA Nuclear Medicine Imaging Agents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 236. SAMEA Nuclear Medicine Imaging Agents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 237. SAMEA Nuclear Medicine Imaging Agents Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 238. SAMEA Nuclear Medicine Imaging Agents Sales by Country (2021-2026) & (K Units) Table 239. SAMEA Nuclear Medicine Imaging Agents Sales by Country (2027-2032) & (K Units) Table 240. SAMEA Nuclear Medicine Imaging Agents Sales Price by Country (2021-2026) & (US$/Unit) Table 241. SAMEA Nuclear Medicine Imaging Agents Sales Price by Country (2027-2032) & (US$/Unit) Table 242. Brazil Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 243. Argentina Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 244. Chile Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 245. Colombia Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 246. Peru Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 247. Saudi Arabia Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 248. Israel Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 249. UAE Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 250. Turkey Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 251. Iran Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 252. Egypt Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Table 253. Key Raw Materials Table 254. Raw Materials Key Suppliers Table 255. Nuclear Medicine Imaging Agents Distributors List Table 256. Nuclear Medicine Imaging Agents Customers List Table 257. Research Programs/Design for This Report Table 258. Authors List of This Report Table 259. Secondary Sources Table 260. Primary Sources List of Figures Figure 1. Nuclear Medicine Imaging Agents Image Figure 2. Global Nuclear Medicine Imaging Agents Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nuclear Medicine Imaging Agents Market Size Share 2021 VS 2025 VS 2032 Figure 4. Nitrogen 13 Labeling Image Figure 5. Technetium 99 Labeling Image Figure 6. Fluorine 18 Labeling Image Figure 7. Carbon 11 Labeling Image Figure 8. Oxygen 15 Labeling Image Figure 9. Others Image Figure 10. Global Nuclear Medicine Imaging Agents Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Nuclear Medicine Imaging Agents Market Size Share 2021 VS 2025 VS 2032 Figure 12. Clinical Stage Image Figure 13. Early Diagnosis Image Figure 14. Treatment Evaluation Image Figure 15. Global Nuclear Medicine Imaging Agents Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Nuclear Medicine Imaging Agents Revenue (2021-2032) & (US$ Million) Figure 17. Global Nuclear Medicine Imaging Agents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Nuclear Medicine Imaging Agents Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Nuclear Medicine Imaging Agents Revenue Market Share by Region (2021-2032) Figure 20. Global Nuclear Medicine Imaging Agents Sales (2021-2032) & (K Units) Figure 21. Global Nuclear Medicine Imaging Agents Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 22. Global Nuclear Medicine Imaging Agents Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Nuclear Medicine Imaging Agents Sales YoY (2021-2032) & (K Units) Figure 24. Europe Nuclear Medicine Imaging Agents Sales YoY (2021-2032) & (K Units) Figure 25. China Nuclear Medicine Imaging Agents Sales YoY (2021-2032) & (K Units) Figure 26. Asia (Excluding China) Nuclear Medicine Imaging Agents Sales YoY (2021-2032) & (K Units) Figure 27. South America, Middle East and Africa Nuclear Medicine Imaging Agents Sales YoY (2021-2032) & (K Units) Figure 28. Global Nuclear Medicine Imaging Agents Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Nuclear Medicine Imaging Agents Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Nuclear Medicine Imaging Agents Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Nuclear Medicine Imaging Agents Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Nuclear Medicine Imaging Agents Revenue Market Share by Type (2021-2032) Figure 34. Global Nuclear Medicine Imaging Agents Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 35. Global Nuclear Medicine Imaging Agents Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Nuclear Medicine Imaging Agents Sales Market Share by Type (2021-2032) Figure 37. Global Nuclear Medicine Imaging Agents Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Nuclear Medicine Imaging Agents Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Nuclear Medicine Imaging Agents Revenue Market Share by Application (2021-2032) Figure 40. Global Nuclear Medicine Imaging Agents Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 41. Global Nuclear Medicine Imaging Agents Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Nuclear Medicine Imaging Agents Sales Market Share by Application (2021-2032) Figure 43. North America Nuclear Medicine Imaging Agents Revenue Share by Type (2021-2032) Figure 44. North America Nuclear Medicine Imaging Agents Sales Share by Type (2021-2032) Figure 45. North America Nuclear Medicine Imaging Agents Revenue Share by Application (2021-2032) Figure 46. North America Nuclear Medicine Imaging Agents Sales Share by Application (2021-2032) Figure 47. North America Nuclear Medicine Imaging Agents Revenue Share by Country (2021-2032) Figure 48. North America Nuclear Medicine Imaging Agents Sales Share by Country (2021-2032) Figure 49. Europe Nuclear Medicine Imaging Agents Revenue Share by Type (2021-2032) Figure 50. Europe Nuclear Medicine Imaging Agents Sales Share by Type (2021-2032) Figure 51. Europe Nuclear Medicine Imaging Agents Revenue Share by Application (2021-2032) Figure 52. Europe Nuclear Medicine Imaging Agents Sales Share by Application (2021-2032) Figure 53. Europe Nuclear Medicine Imaging Agents Revenue Share by Country (2021-2032) Figure 54. Europe Nuclear Medicine Imaging Agents Sales Share by Country (2021-2032) Figure 55. China Nuclear Medicine Imaging Agents Revenue Share by Type (2021-2032) Figure 56. China Nuclear Medicine Imaging Agents Sales Share by Type (2021-2032) Figure 57. China Nuclear Medicine Imaging Agents Revenue Share by Application (2021-2032) Figure 58. China Nuclear Medicine Imaging Agents Sales Share by Application (2021-2032) Figure 59. Asia Nuclear Medicine Imaging Agents Revenue Share by Type (2021-2032) Figure 60. Asia Nuclear Medicine Imaging Agents Sales Share by Type (2021-2032) Figure 61. Asia Nuclear Medicine Imaging Agents Revenue Share by Application (2021-2032) Figure 62. Asia Nuclear Medicine Imaging Agents Sales Share by Application (2021-2032) Figure 63. Asia Nuclear Medicine Imaging Agents Revenue Share by Country (2021-2032) Figure 64. Asia Nuclear Medicine Imaging Agents Sales Share by Country (2021-2032) Figure 65. SAMEA Nuclear Medicine Imaging Agents Revenue Share by Type (2021-2032) Figure 66. SAMEA Nuclear Medicine Imaging Agents Sales Share by Type (2021-2032) Figure 67. SAMEA Nuclear Medicine Imaging Agents Revenue Share by Application (2021-2032) Figure 68. SAMEA Nuclear Medicine Imaging Agents Sales Share by Application (2021-2032) Figure 69. SAMEA Nuclear Medicine Imaging Agents Revenue Share by Country (2021-2032) Figure 70. SAMEA Nuclear Medicine Imaging Agents Sales Share by Country (2021-2032) Figure 71. Nuclear Medicine Imaging Agents Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Nuclear Medicine Imaging Agents Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Nitrogen 13 Labeling
  • Technetium 99 Labeling
  • Fluorine 18 Labeling
  • Carbon 11 Labeling
  • Oxygen 15 Labeling
  • Others
Applications
  • Clinical Stage
  • Early Diagnosis
  • Treatment Evaluation
Companies covered
  • Jubilant Pharma Limited
  • Foshan Rui Diao Pharmaceutical
  • Yantai Dongcheng
  • Navidea
  • Mallinckrodt
  • Lantheus
  • Guerbet
  • GE HealthCare
  • Eli Lilly and Company
  • Cardinal Health
  • Bracco Diagnostic
  • Blue Earth Diagnostics
  • Bayer AG
  • Abx Advanced Biochemical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nuclear Medicine Imaging Agents Market by Type
  3. 1.2.1 Global Nuclear Medicine Imaging Agents Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Nitrogen 13 Labeling
  5. 1.2.3 Technetium 99 Labeling
  6. 1.2.4 Fluorine 18 Labeling
  7. 1.2.5 Carbon 11 Labeling
  8. 1.2.6 Oxygen 15 Labeling
  9. 1.2.7 Others
  10. 1.3 Nuclear Medicine Imaging Agents Market by Application
  11. 1.3.1 Global Nuclear Medicine Imaging Agents Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Clinical Stage
  13. 1.3.3 Early Diagnosis
  14. 1.3.4 Treatment Evaluation
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Nuclear Medicine Imaging Agents Market Dynamics
  1. 2.1 Nuclear Medicine Imaging Agents Industry Trends
  2. 2.2 Nuclear Medicine Imaging Agents Industry Drivers
  3. 2.3 Nuclear Medicine Imaging Agents Industry Opportunities and Challenges
  4. 2.4 Nuclear Medicine Imaging Agents Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Nuclear Medicine Imaging Agents Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Nuclear Medicine Imaging Agents Revenue by Region
  3. 3.2.1 Global Nuclear Medicine Imaging Agents Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nuclear Medicine Imaging Agents Revenue by Region (2021-2026)
  5. 3.2.3 Global Nuclear Medicine Imaging Agents Revenue by Region (2027-2032)
  6. 3.2.4 Global Nuclear Medicine Imaging Agents Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Nuclear Medicine Imaging Agents Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Nuclear Medicine Imaging Agents Sales by Region
  9. 3.4.1 Global Nuclear Medicine Imaging Agents Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Nuclear Medicine Imaging Agents Sales by Region (2021-2026)
  11. 3.4.3 Global Nuclear Medicine Imaging Agents Sales by Region (2027-2032)
  12. 3.4.4 Global Nuclear Medicine Imaging Agents Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Nuclear Medicine Imaging Agents Revenue by Manufacturers
  2. 4.1.1 Global Nuclear Medicine Imaging Agents Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Nuclear Medicine Imaging Agents Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Nuclear Medicine Imaging Agents Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nuclear Medicine Imaging Agents Sales by Manufacturers
  6. 4.2.1 Global Nuclear Medicine Imaging Agents Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Nuclear Medicine Imaging Agents Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Nuclear Medicine Imaging Agents Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Nuclear Medicine Imaging Agents Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Nuclear Medicine Imaging Agents Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Nuclear Medicine Imaging Agents Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Nuclear Medicine Imaging Agents Manufacturers, Product Type & Application
  13. 4.7 Global Nuclear Medicine Imaging Agents Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Nuclear Medicine Imaging Agents Market CR5 and HHI
  16. 4.8.2 2025 Nuclear Medicine Imaging Agents Tier 1, Tier 2, and Tier 3
5 Nuclear Medicine Imaging Agents Market by Type
  1. 5.1 Global Nuclear Medicine Imaging Agents Revenue by Type
  2. 5.1.1 Global Nuclear Medicine Imaging Agents Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Nuclear Medicine Imaging Agents Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Nuclear Medicine Imaging Agents Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Nuclear Medicine Imaging Agents Sales by Type
  6. 5.2.1 Global Nuclear Medicine Imaging Agents Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nuclear Medicine Imaging Agents Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Nuclear Medicine Imaging Agents Sales Market Share by Type (2021-2032)
  9. 5.3 Global Nuclear Medicine Imaging Agents Price by Type
6 Nuclear Medicine Imaging Agents Market by Application
  1. 6.1 Global Nuclear Medicine Imaging Agents Revenue by Application
  2. 6.1.1 Global Nuclear Medicine Imaging Agents Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Nuclear Medicine Imaging Agents Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Nuclear Medicine Imaging Agents Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Nuclear Medicine Imaging Agents Sales by Application
  6. 6.2.1 Global Nuclear Medicine Imaging Agents Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Nuclear Medicine Imaging Agents Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Nuclear Medicine Imaging Agents Sales Market Share by Application (2021-2032)
  9. 6.3 Global Nuclear Medicine Imaging Agents Price by Application
7 Company Profiles
  1. 7.1 Jubilant Pharma Limited
  2. 7.1.1 Jubilant Pharma Limited Company Information
  3. 7.1.2 Jubilant Pharma Limited Business Overview
  4. 7.1.3 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product Portfolio
  6. 7.1.5 Jubilant Pharma Limited Recent Developments
  7. 7.2 Foshan Rui Diao Pharmaceutical
  8. 7.2.1 Foshan Rui Diao Pharmaceutical Company Information
  9. 7.2.2 Foshan Rui Diao Pharmaceutical Business Overview
  10. 7.2.3 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product Portfolio
  12. 7.2.5 Foshan Rui Diao Pharmaceutical Recent Developments
  13. 7.3 Yantai Dongcheng
  14. 7.3.1 Yantai Dongcheng Company Information
  15. 7.3.2 Yantai Dongcheng Business Overview
  16. 7.3.3 Yantai Dongcheng Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Yantai Dongcheng Nuclear Medicine Imaging Agents Product Portfolio
  18. 7.3.5 Yantai Dongcheng Recent Developments
  19. 7.4 Navidea
  20. 7.4.1 Navidea Company Information
  21. 7.4.2 Navidea Business Overview
  22. 7.4.3 Navidea Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Navidea Nuclear Medicine Imaging Agents Product Portfolio
  24. 7.4.5 Navidea Recent Developments
  25. 7.5 Mallinckrodt
  26. 7.5.1 Mallinckrodt Company Information
  27. 7.5.2 Mallinckrodt Business Overview
  28. 7.5.3 Mallinckrodt Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Mallinckrodt Nuclear Medicine Imaging Agents Product Portfolio
  30. 7.5.5 Mallinckrodt Recent Developments
  31. 7.6 Lantheus
  32. 7.6.1 Lantheus Company Information
  33. 7.6.2 Lantheus Business Overview
  34. 7.6.3 Lantheus Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Lantheus Nuclear Medicine Imaging Agents Product Portfolio
  36. 7.6.5 Lantheus Recent Developments
  37. 7.7 Guerbet
  38. 7.7.1 Guerbet Company Information
  39. 7.7.2 Guerbet Business Overview
  40. 7.7.3 Guerbet Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Guerbet Nuclear Medicine Imaging Agents Product Portfolio
  42. 7.7.5 Guerbet Recent Developments
  43. 7.8 GE HealthCare
  44. 7.8.1 GE HealthCare Company Information
  45. 7.8.2 GE HealthCare Business Overview
  46. 7.8.3 GE HealthCare Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 GE HealthCare Nuclear Medicine Imaging Agents Product Portfolio
  48. 7.8.5 GE HealthCare Recent Developments
  49. 7.9 Eli Lilly and Company
  50. 7.9.1 Eli Lilly and Company Company Information
  51. 7.9.2 Eli Lilly and Company Business Overview
  52. 7.9.3 Eli Lilly and Company Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Eli Lilly and Company Nuclear Medicine Imaging Agents Product Portfolio
  54. 7.9.5 Eli Lilly and Company Recent Developments
  55. 7.10 Cardinal Health
  56. 7.10.1 Cardinal Health Company Information
  57. 7.10.2 Cardinal Health Business Overview
  58. 7.10.3 Cardinal Health Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Cardinal Health Nuclear Medicine Imaging Agents Product Portfolio
  60. 7.10.5 Cardinal Health Recent Developments
  61. 7.11 Bracco Diagnostic
  62. 7.11.1 Bracco Diagnostic Company Information
  63. 7.11.2 Bracco Diagnostic Business Overview
  64. 7.11.3 Bracco Diagnostic Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Bracco Diagnostic Nuclear Medicine Imaging Agents Product Portfolio
  66. 7.11.5 Bracco Diagnostic Recent Developments
  67. 7.12 Blue Earth Diagnostics
  68. 7.12.1 Blue Earth Diagnostics Company Information
  69. 7.12.2 Blue Earth Diagnostics Business Overview
  70. 7.12.3 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product Portfolio
  72. 7.12.5 Blue Earth Diagnostics Recent Developments
  73. 7.13 Bayer AG
  74. 7.13.1 Bayer AG Company Information
  75. 7.13.2 Bayer AG Business Overview
  76. 7.13.3 Bayer AG Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Bayer AG Nuclear Medicine Imaging Agents Product Portfolio
  78. 7.13.5 Bayer AG Recent Developments
  79. 7.14 Abx Advanced Biochemical
  80. 7.14.1 Abx Advanced Biochemical Company Information
  81. 7.14.2 Abx Advanced Biochemical Business Overview
  82. 7.14.3 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product Portfolio
  84. 7.14.5 Abx Advanced Biochemical Recent Developments
8 North America
  1. 8.1 North America Nuclear Medicine Imaging Agents Market Size by Type
  2. 8.1.1 North America Nuclear Medicine Imaging Agents Revenue by Type (2021-2032)
  3. 8.1.2 North America Nuclear Medicine Imaging Agents Sales by Type (2021-2032)
  4. 8.1.3 North America Nuclear Medicine Imaging Agents Price by Type (2021-2032)
  5. 8.2 North America Nuclear Medicine Imaging Agents Market Size by Application
  6. 8.2.1 North America Nuclear Medicine Imaging Agents Revenue by Application (2021-2032)
  7. 8.2.2 North America Nuclear Medicine Imaging Agents Sales by Application (2021-2032)
  8. 8.2.3 North America Nuclear Medicine Imaging Agents Price by Application (2021-2032)
  9. 8.3 North America Nuclear Medicine Imaging Agents Market Size by Country
  10. 8.3.1 North America Nuclear Medicine Imaging Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Nuclear Medicine Imaging Agents Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Nuclear Medicine Imaging Agents Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Nuclear Medicine Imaging Agents Market Size by Type
  2. 9.1.1 Europe Nuclear Medicine Imaging Agents Revenue by Type (2021-2032)
  3. 9.1.2 Europe Nuclear Medicine Imaging Agents Sales by Type (2021-2032)
  4. 9.1.3 Europe Nuclear Medicine Imaging Agents Price by Type (2021-2032)
  5. 9.2 Europe Nuclear Medicine Imaging Agents Market Size by Application
  6. 9.2.1 Europe Nuclear Medicine Imaging Agents Revenue by Application (2021-2032)
  7. 9.2.2 Europe Nuclear Medicine Imaging Agents Sales by Application (2021-2032)
  8. 9.2.3 Europe Nuclear Medicine Imaging Agents Price by Application (2021-2032)
  9. 9.3 Europe Nuclear Medicine Imaging Agents Market Size by Country
  10. 9.3.1 Europe Nuclear Medicine Imaging Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Nuclear Medicine Imaging Agents Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Nuclear Medicine Imaging Agents Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Nuclear Medicine Imaging Agents Market Size by Type
  2. 10.1.1 China Nuclear Medicine Imaging Agents Revenue by Type (2021-2032)
  3. 10.1.2 China Nuclear Medicine Imaging Agents Sales by Type (2021-2032)
  4. 10.1.3 China Nuclear Medicine Imaging Agents Price by Type (2021-2032)
  5. 10.2 China Nuclear Medicine Imaging Agents Market Size by Application
  6. 10.2.1 China Nuclear Medicine Imaging Agents Revenue by Application (2021-2032)
  7. 10.2.2 China Nuclear Medicine Imaging Agents Sales by Application (2021-2032)
  8. 10.2.3 China Nuclear Medicine Imaging Agents Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nuclear Medicine Imaging Agents Market Size by Type
  2. 11.1.1 Asia Nuclear Medicine Imaging Agents Revenue by Type (2021-2032)
  3. 11.1.2 Asia Nuclear Medicine Imaging Agents Sales by Type (2021-2032)
  4. 11.1.3 Asia Nuclear Medicine Imaging Agents Price by Type (2021-2032)
  5. 11.2 Asia Nuclear Medicine Imaging Agents Market Size by Application
  6. 11.2.1 Asia Nuclear Medicine Imaging Agents Revenue by Application (2021-2032)
  7. 11.2.2 Asia Nuclear Medicine Imaging Agents Sales by Application (2021-2032)
  8. 11.2.3 Asia Nuclear Medicine Imaging Agents Price by Application (2021-2032)
  9. 11.3 Asia Nuclear Medicine Imaging Agents Market Size by Country
  10. 11.3.1 Asia Nuclear Medicine Imaging Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Nuclear Medicine Imaging Agents Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Nuclear Medicine Imaging Agents Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nuclear Medicine Imaging Agents Market Size by Type
  2. 12.1.1 SAMEA Nuclear Medicine Imaging Agents Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Nuclear Medicine Imaging Agents Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Nuclear Medicine Imaging Agents Price by Type (2021-2032)
  5. 12.2 SAMEA Nuclear Medicine Imaging Agents Market Size by Application
  6. 12.2.1 SAMEA Nuclear Medicine Imaging Agents Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Nuclear Medicine Imaging Agents Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Nuclear Medicine Imaging Agents Price by Application (2021-2032)
  9. 12.3 SAMEA Nuclear Medicine Imaging Agents Market Size by Country
  10. 12.3.1 SAMEA Nuclear Medicine Imaging Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Nuclear Medicine Imaging Agents Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Nuclear Medicine Imaging Agents Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Nuclear Medicine Imaging Agents Value Chain Analysis
  2. 13.1.1 Nuclear Medicine Imaging Agents Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Nuclear Medicine Imaging Agents Production Mode & Process
  6. 13.2 Nuclear Medicine Imaging Agents Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Nuclear Medicine Imaging Agents Distributors
  9. 13.2.3 Nuclear Medicine Imaging Agents Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst